The U.S. Department of Justice, specifically the Federal Bureau of Prisons at FMC Devens, is seeking quotes for the procurement of Selexipag 200mcg tablets (trade name: Uptravi) under solicitation number 15B20525Q00000011. The requirement includes a total of 180 units of the specified pharmaceutical, which is critical for cardiovascular treatment within the prison system. Proposals must be submitted by 10:00 a.m. EST on February 4, 2025, with the evaluation criteria focusing on the lowest price that meets the technical specifications outlined in the solicitation. Interested vendors should direct their quotes to Charles Coushaine at ccoushaine@bop.gov, ensuring compliance with all federal regulations and requirements.